Key facts
- This page summarizes Micheline Chau's Form 4 filing for Dolby Laboratories, Inc. (DLB).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 09 Feb 2023, 20:29.
Micheline Chau - 07 Feb 2023 Form 4 Insider Report for Dolby Laboratories, Inc. (DLB)
- Reporting relationship
- Director
- Issuer ticker
- DLB
- Reported as of
- 07 Feb 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 09 Feb 2023, 20:29:13 UTC
- Prior SEC filing
- 13 May 2022
- Next SEC filing
- 15 May 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Daniel Rodriguez, as Attorney-in-Fact for Micheline Chau
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Micheline Chau filed Form 4 for Dolby Laboratories, Inc. (DLB) on 09 Feb 2023.
Change
- Previous filing in this sequence was filed on 13 May 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DLB
transaction
Class A Common Stock
Award
- Transaction value
- $0
- Shares
- +3,296
- Change %
- +5.2%
- Price
- $0.000000
- Shares after
- 66,882
- Date
- 07 Feb 2023
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Award represents a total of 3,296 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting, which will occur on the earlier of (i) the first anniversary of the date of grant or (ii) the date immediately preceding the date of Issuer's 2024 annual meeting of stockholders, provided that, in either case, the Reporting Person continues to serve as a member of the Issuer's board of directors on such date.
Footnote F2
Shares held following the reported transactions include 3,296 restricted stock units, which are subject to forfeiture until they vest.